REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/08/2025
Back to search
Official data from USPTO
ALTHEIA SCIENCE TOWARDS CURATIVE MEDICINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
12/09/2025
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
02/28/2020
Registration date
12/08/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/08/2020
Last transaction
12/09/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
IT
Examiner
O'BRIEN,JENNIFER LYNN
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consist of in the words "ALTHEIA SCIENCE TOWARDS CURATIVE MEDICINE" and in the image of a tree connected with a DNA sequence.
Holders and representatives
Holders
ALTHEIA SCIENCE S.r.L.
Representatives
Alexander Lazouski LAZOUSKI IP LLC
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Reagents for use in medical genetic testing; food for diabeticsdietetic foods adapted for medical use; anti-diabetic preparations; anti-diabetic pharmaceuticals; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the prevention of diabetes; chemical preparations for pharmaceutical or medical purposesfor the diagnosis of diabetes; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for regulating the immune system; pharmaceutical drugs in the nature of pharmaceutical preparations for the treatment of autoimmune diseasesrare disease and cancers; pharmaceutical preparations for use in hematologyfor the treatment of autoimmune diseasesrare disease and cancers; stem cells for medical or veterinary use; stem cells for medical purposes; surgical implants comprising living tissue grown from stem cells; drugs in the nature of pharmaceutical preparations for treating diabetes; drugs in the nature of pharmaceutical preparations for treating multiple sclerosis
Class 42
Genetic research; genetic engineering services; Genetic testing for scientific research purposesgenetic fingerprinting; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; advisory services relating to gene therapy research; research in the field of gene therapy; stem cell research; all the above-mentioned services in the field of autoimmune diseasesrare disease and cancers
Class 44
Genetic testing for medical purposes; medical and health services relating to DNAgenetics and genetic testing; therapy servicesspeech therapy servicesmedicalphysical rehabilitation and physical therapy servicescognitive therapy services; Medical diabetes screening services; medical services in the field of diabetes; providing information via the Internet in the field of diabetes; medical laboratory services for the analysis of blood samples taken from patientsmedical analysis services for diagnostic and treatment purposes provided by medical laboratories; stem cell storagetissue bank services; medical services relating to the removaltreatment and processing of stem cells; therapy for diabetesmedicalphysical rehabilitation and physical therapy services; therapy for multiple sclerosismedicalphysical rehabilitation and physical therapy services; lymphocyte gene therapyfor therapeutic purposes; haemopoietic stem cell gene therapyfor therapeutic purposes; all the above-mentioned services in the field of autoimmune diseasesrare disease and cancers
Publications
History of USPTO decisions and trademark events.
22 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/11/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/11/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
03/11/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/08/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
12/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/22/2020
PUBO
PUBLISHED FOR OPPOSITION
09/22/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/28/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/27/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/27/2020
RFNT
REFUSAL PROCESSED BY IB
07/03/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/15/2020
RFRR
REFUSAL PROCESSED BY MPU
06/15/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/26/2020
CNRT
NON-FINAL ACTION WRITTEN
05/25/2020
DOCK
ASSIGNED TO EXAMINER
05/18/2020
MAFR
APPLICATION FILING RECEIPT MAILED
05/12/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/08/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/07/2020
Continuous trademark protection
Get notified about every new filing that threatens ALTHEIA SCIENCE TOWARDS CURATIVE MEDICINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.